Genetic alterations have been described, such as the MECOM gene related to cell development and differentiation, more frequent in leukaemia, which when present in ovarian cancer, is associated with a better prognosis and a longer disease-free interval. This evidence concerns the gene MECOM and ovarian carcinoma.